PRA Opens Office in Romania

RALEIGH, North Carolina, August 22, 2011 -

- Coverage Area Includes the Republic of Moldova

PRA, a leading Clinical Research Organization, recently opened a new office in Bucharest, Romania to further strengthen our coverage of the Balkan region’s burgeoning markets. The Bucharest office will also support projects in the neighboring Republic of Moldova.

Since 2006, when PRA began conducting clinical trials in Romania, the PRA staff has steadily increased and now includes both product registration and early phase professionals. The number of studies initiated by PRA in this region has more than doubled over the last two years.

“By being based in the Balkan region’s key business and life sciences hub, the Bucharest staff has convenient access to top universities, academic research sites, and most of the country’s major hospitals,” said Ludger Langer, PRA’s Vice President of Clinical Operations in Europe, Asia-Pacific and Africa.

The Bucharest location is the 12th office PRA has opened worldwide since 2009, demonstrating our commitment to meeting our clients’ diverse needs in a dynamic clinical trials environment.

About PRA

PRA is transforming clinical trials through our people, innovation and transparency. PRA provides personalized service customized to the unique requirements of each study. We support our global reach and innovative approach through flexible and reliable service, delivered by skilled employees dedicated to ensuring that sponsors achieve their long-term goals.

We serve our clients across all phases of pharmaceutical and biotech drug development by combining therapeutic and operational expertise with local knowledge. Offering services in 80+ countries and serving sponsors for 30+ years, we have amassed a level of expertise that has enabled us to work on a variety of compounds, ranging from niche treatments and therapies to blockbuster drugs. But at PRA, we are looking to the future, not the past. Our increasingly forward-thinking approach to transforming the clinical trial landscape will continue to make a difference to healthcare patients around the world.

To learn more about PRA, please visit praintl.com, email endpoints@praintl.com or call our Global Headquarters.

Roger Boutin, Senior Director - Marketing of PRA, +1-434-951-3924